Supplementary Table 1: Cutaneous adverse events associated with MEK-inhibitors for the treatment of vascular anomalies: a multicenter retrospective study

Supplementary Table 1: Most common cutaneous adverse events observed in patients with vascular anomalies taking MEK-inhibitors, excluding patients on concurrent therapies.